EYSINS, Switzerland, July 29, 2024 /PRNewswire/ -- AliveDx ("Company") is proud to announce it has received IVDR CE mark for its groundbreaking microarray immunoassay, designed for the detection ...

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results from ...

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technologyResearch builds on ...

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is pleased to announce the launch of its new line of Circulatory System Tissue Microarrays to the ...

HAYWARD, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Biolog, Inc., a leading provider of cell-based microbial phenotypic profiling and identification products, including the company's high ...

The clinical study aims to evaluate a vaccine for avian influenza A (H7N9) delivered by Vaxxas’ high-density microarray patch (HD-MAP), and is funded by the United States government as a ...